[go: up one dir, main page]

Levine et al., 1987 - Google Patents

Hypercalcemia: pathophysiology and treatment

Levine et al., 1987

Document ID
2345018594564205174
Author
Levine M
Kleeman C
Publication year
Publication venue
Hospital Practice

External Links

Snippet

Improved technology, which has led to much earlier detection of hypercalcemia, has also made its etiologic diagnosis much more challenging. With a laboratory report of hypercalcemia in a minimally symptomatic patient, physicians must first establish the finding …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Inzucchi Understanding hypercalcemia: its metabolic basis, signs, and symptoms
Elomaa et al. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases
Cooke et al. Antacid-induced osteomalacia and nephrolithiasis
Lafferty et al. Skeletal, intestinal and renal calcium dynamics in hyperparathyroidism
Pletka et al. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis
Jacobs et al. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium
Kleeman et al. The problem and unanswered questions: Renal osteodystrophy, soft tissue calcification, and disturbed divalent ion metabolism in chronic renal failure
Lau et al. Differing effects of acid versus neutral phosphate therapy of hypercalciuria
GOLD et al. The effect of lithium on the osmoregulation of arginine vasopressin secretion
Knutsen et al. Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks
AU634988B2 (en) Treatment of hypertension
Ludwig et al. “Tertiary” hyperparathyroidism induced by osteomalacia resulting from phosphorus depletion
Thibonnier et al. Abnormal regulation of antidiuretic hormone in idiopathic edema
Rosenberg et al. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta
Levine et al. Hypercalcemia: pathophysiology and treatment
Wilson et al. Hyperparathyroidism in pregnancy: case report and review of the literature
Booth et al. Hypomagnesemia due to renal tubular defect in reabsorption of magnesium
HOWARD et al. Clinical disorders of calcium homeostasis
Bijvoet et al. The interpretation of laboratory tests in bone disease
Popovtzer et al. Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease
Bauer et al. Studies on the mode of action of irradiated ergosterol: IV. In hypoparathyroidism
Nair et al. Influence of magnesium on the secretion and action of parathyroid hormone
KNOWLTON et al. Lack of effect of hypophysectomy upon metastatic adrenocortical carcinoma with Cushing's syndrome: a case report
Ihde Paraneoplastic syndromes
Aloia et al. Biochemical short-term changes produced by hormonal replacement therapy